← Back to Search

Behavioural Intervention

SweetDreams for Autism Spectrum Disorder

N/A
Waitlist Available
Led By Lauren Asarnow, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to end of treatment (anticipated average exposure 1 month)
Awards & highlights

Summary

This trial will test an online program called SweetDreams that helps preschool-aged children with Autism Spectrum Disorder (ASD) sleep better. The program provides videos and educational materials for parents, making it easier for them to get help. It can be accessed on computers, tablets, and phones.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism
  • Insomnia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to end of treatment (anticipated average exposure 1 month)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to end of treatment (anticipated average exposure 1 month) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Children's Sleep Habits Questionnaire (CSHQ)
Secondary outcome measures
Change in Pittsburgh Sleep Quality Index (PSQI)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SweetDreamsExperimental Treatment1 Intervention
Access to a mobile and computer accessible adaptation of existing evidence based sleep interventions.
Group II: Waitlist ControlActive Control1 Intervention
Wait list condition with future access to a mobile and computer accessible adaptation of existing evidence based sleep interventions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SweetDreams
2020
N/A
~20

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,528 Previous Clinical Trials
15,242,612 Total Patients Enrolled
6 Trials studying Autism Spectrum Disorder
237 Patients Enrolled for Autism Spectrum Disorder
Lauren Asarnow, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
112 Total Patients Enrolled
~4 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top